Glucocorticoids in muscular dystrophy: beneficial effects of dexamethasone on avian myopathy
- 1 August 1988
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 2 (11) , 2722-2725
- https://doi.org/10.1096/fasebj.2.11.3396809
Abstract
A corticosteroid with mixed glucocorticoid-mineralocorticoid actions was previously shown to improve neuromuscular function in muscular dystrophic chickens. The significance of that finding was recently underscored by reports that a mixed-action corticosteroid improved muscle function in Duchenne dystrophy patients, albeit at high doses. In the present study a pure glucocorticoid improved function and retarded muscle histopathology in the chicken, but a pure mineralocorticoid did not. These observations suggest that elucidation of mechanisms by which glucocorticoids beneficially affect dystrophic muscle could lead to development of more effective therapies.This publication has 7 references indexed in Scilit:
- Prednisone Treatment in Duchenne Muscular DystrophyArchives of Neurology, 1987
- Clinical Investigation of Duchenne Muscular DystrophyArchives of Neurology, 1987
- Treatment of duchenne muscular dystrophy with growth hormone inhibitorsAmerican Journal of Medical Genetics, 1986
- Drugs in muscular dystrophy of the chicken: Corticosterone ‐21‐acetateMuscle & Nerve, 1984
- Water deprivation: Beneficial effect on muscular dystrophy in chickensExperimental Neurology, 1983
- Drug evaluation in muscular dystrophy of the chickenMuscle & Nerve, 1982
- Avian Muscular Dystrophy: Functional and Biochemical Improvement with DiphenylhydantoinScience, 1977